ClinConnect ClinConnect Logo
Search / Trial NCT07040631

Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness

Launched by PUSAN NATIONAL UNIVERSITY YANGSAN HOSPITAL · Jun 24, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Postoperative Sore Throat Hyaluronic Acid Lubricating Gel Endotracheal Intubation Hoarseness Breast Cancer Surgery Randomized Controlled Trial

ClinConnect Summary

This clinical trial is studying whether a special gel called Endotra Gel, made from a substance called hyaluronic acid, can help prevent sore throat, hoarseness, and coughing after surgery. These symptoms often happen when a breathing tube (called an endotracheal tube) is placed in the windpipe during general anesthesia. The gel would be applied to the breathing tube before surgery to see if it can reduce irritation and make recovery more comfortable.

Adults between 19 and 80 years old who are having breast cancer surgery under general anesthesia with a breathing tube may be eligible to join the study. People with certain airway conditions, recent throat infections, or other health issues may not qualify. If you participate, you will be randomly placed into one of two groups: one that gets the gel applied to the breathing tube, and one that receives the usual care without the gel. After surgery, you will be asked about any sore throat, hoarseness, or coughing, both right after and the day following your operation. The goal is to learn if this gel can help improve comfort and reduce throat irritation after surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged 19 to 80 years
  • Scheduled to undergo breast cancer surgery under general anesthesia with endotracheal intubation
  • American Society of Anesthesiologists (ASA) physical status I to III
  • Exclusion Criteria:
  • Mallampati classification of III or higher
  • Recent upper respiratory infection or symptoms of upper airway infection
  • Pre-existing laryngeal disease or chronic respiratory conditions (e.g., asthma, chronic bronchitis)
  • Current use of systemic steroids
  • Refusal to provide informed consent
  • Determined to be unsuitable for study participation by the investigator

About Pusan National University Yangsan Hospital

Pusan National University Yangsan Hospital is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to investigate new therapies, improve treatment protocols, and enhance patient outcomes. With a commitment to ethical standards and rigorous scientific methodology, Pusan National University Yangsan Hospital collaborates with multidisciplinary teams to ensure the highest quality of clinical research, contributing significantly to the global medical community and fostering advancements in healthcare.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported